Clinical Trial Update: A Phase I Study of GZR18 Injection in Obese/Overweight Subjects [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating GZR18 injection in overweight and obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• GZR18

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED